AcouSort Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

AcouSort hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

n/a

Ausschüttungsquote

Durchschnittlicher Branchenertrag	1.8%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Gewinn pro Aktie	-SEK 1.19
Erwartete Dividendenrendite in 3 Jahren	n/a

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von ACOU in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von ACOU gestiegen sind.

Dividendenrendite im Vergleich zum Markt

AcouSort Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von ACOU im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (ACOU)	n/a
Untere 25 % des Marktes (SE)	1.4%
Markt Top 25 % (SE)	4.2%
Branchendurchschnitt (Biotechs)	1.8%
Analystenprognose in 3 Jahren (ACOU)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von ACOU im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von ACOU im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von ACOU, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da ACOU keine Ausschüttungen gemeldet hat.

AcouSort Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

Recent updates

First quarter 2024 earnings released: kr0.25 loss per share (vs kr0.23 loss in 1Q 2023)

AcouSort AB (publ) to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation

Full year 2023 earnings released: kr1.29 loss per share (vs kr1.04 loss in FY 2022)

New minor risk - Share price stability

Founder & Independent Director recently bought kr52k worth of stock

AcouSort AB (publ) to Report Q3, 2024 Results on Nov 27, 2024

New minor risk - Shareholder dilution

AcouSort AB (publ) has completed a Composite Units Offering.

Third quarter 2023 earnings released: kr0.33 loss per share (vs kr0.32 loss in 3Q 2022)

New major risk - Share price stability

AcouSort AB (publ) to Report Q4, 2023 Results on Feb 28, 2024

New major risk - Financial position

New minor risk - Share price stability

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

AcouSort AB (publ) Recruits Henrik Johansson to the Position as Director of Research and Technology

First quarter 2023 earnings released: kr0.23 loss per share (vs kr0.20 loss in 1Q 2022)

AcouSort AB (publ) Launches Next Generation AcouTrap at CYTO 2023

Full year 2022 earnings released: kr0.98 loss per share (vs kr0.92 loss in FY 2021)

Founder & Independent Director recently bought kr68k worth of stock

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

Third quarter 2022 earnings released: kr0.32 loss per share (vs kr0.30 loss in 3Q 2021)

Second quarter 2022 earnings released: kr0.31 loss per share (vs kr0.31 loss in 2Q 2021)

The European Innovation Council Awards the Acousort Project Acousome SEK 26 Million to Develop Technology for Exosome-Based Diagnostics

AcouSort AB Announces Executive Appointments

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

AcouSort AB (publ) and Werfen's Joint Patent Application Has Received National Approval in US

AcouSort AB (publ) Announces Scientific Progress with AcouWash Enables New Method for Cancer Treatment Monitoring

First quarter 2022 earnings released: kr0.20 loss per share (vs kr0.15 loss in 1Q 2021)

Founder & Independent Director recently bought kr95k worth of stock

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort AB (publ) to Report Fiscal Year 2021 Results on Apr 13, 2022

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort will launch AcouWash 2 at international conference

Second quarter 2021 earnings released: kr0.31 loss per share (vs kr0.12 loss in 2Q 2020)

AcouSort AB (publ) Announces Development Process of AcouPlasma Optical Reaches Important Milestone

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.10 loss in 1Q 2020)

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

Acousort Strengthens Commercial Offering with the Release of New Acouwash Application Notes

Full year 2020 earnings released: kr0.70 loss per share (vs kr0.96 loss in FY 2019)

AcouSort AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

AcouSort AB (publ) to Report Q3, 2021 Results on Nov 24, 2021

AcouSort AB Enters Collaboration Agreement with Belgian Diagnostics Company

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Physio-Tech Co.,Ltd. acquired AcouTrap system from AcouSort AB (publ) (OM:ACOU).

New 90-day high: kr26.90

New 90-day high: kr22.30

New 90-day high: kr21.80

Third quarter 2020 earnings released: kr0.20 loss per share

New 90-day high: kr19.25

New 90-day high: kr16.85

New 90-day high: kr12.40

Stabilität und Wachstum des Zahlungsverkehrs

Dividendenrendite im Vergleich zum Markt

Gewinnausschüttung an die Aktionäre

Barausschüttung an die Aktionäre

Entdecken Sie dividendenstarke Unternehmen